Clinicopathologic Conference, Glioblastonoma, WHO grade IV of IV, with Methylation of the MGMT Promoter
NEJM 366:2112-2120, Case 17-2012, 2012
Diagnostic Evaluation of Patients with a Brain Mass as the Presenting Manifestation of Cancer
Neurol 65:908-911, Mavrakis,A.N.,et al, 2005